to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Angel investors in the life sciences talk about when, why and how to seek angel funding for your pharmaceutical, mobile and medical device startups.
Business conditions are tough for new healthcare businesses, but slivers of sunlight are shooting through the clouds. Take advantage by setting the stage for a small business loan.
Whether it's to protect against a natural disaster, fire, or theft, backing up a companies electronic files is a necessity. Online backup services provide storage of valuable information at a location separate from the entrepreneur's company.
Investors in bioscience are looking not just for financial returns, but societal returns over the long haul in a global economy. And that will take collaborative efforts and a crowdsourcing of expertise as well as capital.
This exceptional article offers insightful explanation and key details of how angel investors determine valuations, why entrepreneurs and investors often have different perspectives for angel returns, and what steps angels and entrepreneurs can take to quickly find common ground on this critical topic.
When pitching a potential investor, it is important to understand not only what they want to hear, but more importantly what they don't. Avoid these typical mistakes that many entrepreneurs make when seeking funding from angels and venture capitalists.
This tool will help you prepare answers to an investor's due diligence questions.
Local investing could be the answer to the problem of dealing with big banks and the way they do business. Read more about this funding alternative for startups.
Being a public company has upsides, such as increased value of your company and stock liquidity. Entrepreneurs, though, should realize the downsides, such as compliance costs and lack of personal and company privacy. Looking thoroughly at the entire picture will help you decide whether going public is your best move.
Valuation negotiations between entrepreneurs and investors are often contentious. Such valuations rarely stray from the $1 million to $3 million range for seed/startup companies that angels expect to grow to $50 million to $100 million over five to eight years. Angels are most concerned about the management team's ability to rapidly grow the company and about helping the entrepreneur achieve these growth objectives.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.